[The effectiveness of Cytoflavin in the medical rehabilitation of elderly and senile patients].

Aim: Study the effectiveness of Cytoflavin in the medical rehabilitation of elderly and senile patients after pneumonia associated with a new coronavirus infection (COVID-19) at the outpatient stage.

Materials And Methods: A prospective observational randomized study involving 66 patients (45 women and 21 men, average age 66.5±5.

[Efficacy and safety of levilimab in the treatment of patients with rheumatoid arthritis].

Aim: Evaluation in real clinical practice of the effectiveness and safety of levilimab therapy in patients with highly and moderately active rheumatoid arthritis (RA).

Materials And Methods: A prospective observational study (6 months) involving 35 patients with RA (29 women and 6 men, mean age 53.17±13.

[Variants of the clinical course of the acute period of ischemic stroke in young and middle-aged patients].

Objective: To identify and study variants of the clinical course of the acute period of ischemic stroke (IS) in young and middle-aged patients, to establish their dependence on the presence of the main risk factors for cardiovascular diseases.

Material And Methods: The study included 145 patients (111 men and 34 women) with IS in its acute period, including 22 young (15.2%) and 123 middle-aged people (84.

[Analysis of the dynamics of mortality from respiratory diseases in the Russian Federation for 2019-2020].

Aim: To study the dynamics and contribution of mortality from Diseases of the respiratory system (DRS) in 2019 and 2020 to mortality from all causes with and without deaths from COVID-19 in 82 regions of the Russian Federation.

Materials And Methods: The data provided by Rosstat for 2019 and 2020 on the average annual population and the number of deaths due to causes of DRS (class J00J99) were used the standardised death rate (SDR) were calculated, the regional average value, standard deviation and coefficient of variation.

Results: The average increase in the SDR from DRS in 2020 was 22.

[Experience of using a triple fixed combination in the treatment of patients with chronic obstructive pulmonary disease].

Aim: To evaluate the effectiveness of a fixed triple combination of vilanterol/umeclidinium bromide/fluticasone furoate in the treatment of chronic obstructive pulmonary disease (COPD) patients with frequent exacerbations.

Materials And Methods: The study included 46 patients with severe and extremely severe COPD (GOLD 34) with frequent exacerbations. All patients were divided into 2 groups.